실로파마, 2026-02-23 8-K 제출…비상장 지분증권 관련 공시
8-K - Silo Pharma, Inc. (0001514183) (Filer)
실로 파마의 8-K 신고서는 거래 관련 내용이 주를 이루며, 단기적인 긍정적 또는 부정적 카탈리스트가 명확하지 않아 중립적인 입장을 취하는 것이 적합합니다.
핵심 요약
실로파마 8-K(2026-02-23, 17:00:43)가 Item 3.02·8.01·9.01 공시와 13개 문서 제출 내역을 공개했다.
실로파마(Silo Pharma, Inc., CIK 0001514183)가 2026년 2월 23일에 8-K를 제출했으며, 접수일·수락일은 모두 2026-02-23이고 수락 시각은 17:00:43이다. 보고 기간은 2026-02-20로, 항목 3.02(비상장 주식증권 매각), 8.01(기타 사건), 9.01(재무제표 및 부속 서류)이 포함됐다. 제출 서류는 총 13개로, 본문 8-K(iXBRL), 보도자료(EX-99.1), XBRL 스키마·라벨·프레젠테이션·인스턴스 문서 등을 포함한다.
원문 링크: https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/0001213900-26-019384-index.htm
Original Article
8-K - Silo Pharma, Inc. (0001514183) (Filer)
EIN. : 462137136 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 26666163 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
Form 8-K - Current report: SEC Accession No. 0001213900-26-019384 Filing Date 2026-02-23 Accepted 2026-02-23 17:00:43 Documents 13 Period of Report 2026-02-20 Items Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0278025-8k_silo.htm iXBRL 8-K 27484 2 PRESS RELEASE OF SILO PHARMA, INC. DATED FEBRUARY 23, 2026 ea027802501ex99-1_silo.htm EX-99.1 6677 Complete submission text file 0001213900-26-019384.txt 200411 Data Files Seq Description Document Type Size 3 XBRL SCHEMA FILE silo-20260220.xsd EX-101.SCH 3020 4 XBRL LABEL FILE silo-20260220_lab.xml EX-101.LAB 34239 5 XBRL PRESENTATION FILE silo-20260220_pre.xml EX-101.PRE 22362 15 EXTRACTED XBRL INSTANCE DOCUMENT ea0278025-8k_silo_htm.xml XML 3094 Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031 Silo Pharma, Inc. (Filer) CIK : 0001514183 (see all company filings) EIN. : 462137136 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 26666163 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
Form 8-K - Current report: SEC Accession No. 0001213900-26-019384
Filing Date 2026-02-23 Accepted 2026-02-23 17:00:43 Documents 13 Period of Report 2026-02-20 Items Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data
Filing Date 2026-02-23 Accepted 2026-02-23 17:00:43 Documents 13
Items Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0278025-8k_silo.htm iXBRL 8-K 27484 2 PRESS RELEASE OF SILO PHARMA, INC. DATED FEBRUARY 23, 2026 ea027802501ex99-1_silo.htm EX-99.1 6677 Complete submission text file 0001213900-26-019384.txt 200411
Source: https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/0001213900-26-019384-index.htm